OR18 Therapy of Pituitary Tumors

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Neuroendocrinology and Pituitary-Translational
Saturday, April 2, 2016: 11:45 AM-1:15 PM
Room 107 (BCEC)
Chairs:
Márta Korbonits, MD, PhD, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom and John David Carmichael, MD, University of Southern California, Los Angeles, CA

Disclosures:
MK: Advisory Group Member, Pfizer, Inc., Investigator, Pfizer, Inc., Investigator, Novartis Pharmaceuticals, Advisory Group Member, AeternaZentaris. JDC: Advisory Group Member, Pfizer, Inc., Principal Investigator, Pfizer, Inc., Principal Investigator, Novo Nordisk, Speaker, Novartis Pharmaceuticals, Advisory Group Member, Chiasma, Principal Investigator, Novartis Pharmaceuticals, Investigator, Novartis Pharmaceuticals. Disclosure Not Provided: GA
11:45 AM
Nicholas A Tritos, DSc, MD1, Philippe Chanson, MD, PHD2, Camilo Jimenez, M.D.3, Donna King, PhD4, Peter J. Jonsson, MSc5, Anne Klibanski, MD1 and Beverly M.K. Biller, MD, FACP1, (1)Neuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA
(2)Institut National de la Santé et de la Recherche Médicale U693,, Univ Paris-Sud, UMR-S693, Le Kremlin Bicêtre, France, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Le Kremlin Bicêtre, Paris, France, Le Kremlin-Bicêtre, France
(3)Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX
(4)Endocrine Care, Pfizer Inc, Lawrenceville, NJ
(5)Endocrine Care, Pfizer Health AB, Sollentuna, Sweden
12:00 PM
Christian J Strasburger, MD, Endocrinology, Diabetes and Nutritional Medicine, Charité-Universitätsmedizin, Berlin, Germany, Laurence Katznelson, MD, Stanford University, Stanford, CA, Shlomo Melmed, MB, ChB, Academic Affairs Administration, Cedars-Sinai Medical Center, Los Angeles, CA, Asi Haviv, Chiasma, Jerusalem, Israel, Gary Patou, Chiasma Inc,, Newton, MA and Nienke R. Biermasz, MD, PhD, Department of Medicine: Division of Endocrinology, Center for Endocrine Tumors, Leiden University Medical Center, Leiden, Netherlands
12:15 PM
Juan Diego Palacios, MD, ENDOCRINOLOGY DIABETES METABOLISM, UNIVERSITY OF MIAMI/JACKSON MEMORIAL HOSPITAL, Miami, FL and Atil Yilmaz Kargi, MD., Endocrinology, University of Miami Miller School of Medicine, Miami, FL
12:30 PM
Pia Burman, MD, PhD, Department of Endocrinology, Skane University Hospital, Malmö, University of Lund, Malmo, Sweden, André P. van Beek, MD PhD, Department of Endocrinology, University Medical Center Groningen, Groningen, Netherlands, Beverly M.K. Biller, MD, FACP, Neuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, Cecilia Camacho-Hubner, MD, Endocrine Care, Pfizer Inc, New York, NY and Anders F. Mattsson, PhD, Pfizer Endocrine Care, Sollentuna, Pfizer Health AB, Sollentuna, Sweden
12:45 PM
Eleni Daniel, MSc MRCP, Department of Human Metabolism, University of Sheffield, Sheffield, United Kingdom, Miguel Debono, MD, MRCP, PhD, Human Metabolism, Academic Unit of Endocrinology, University of Sheffield, Sheffield, United Kingdom, Sharon Caunt, PhD, Academic Directorate of Diabetes & Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, Constantine Girio-Fragkoulakis, MSc, Clinical Radiology, Nottingham University Hospitals, Scott Alexander Akker, Endocrinology, St Bartholomew's Hospital, London, United Kingdom, Ashley B. Grossman, MD, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom, Peter J. Trainer, MD, FRCP, Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, United Kingdom and John Newell-Price, MD, PhD, FRCP, Department of Human Metabolism, University of Sheffield and Department of Endocrinology, Sheffield Teaching Hospitals, Sheffield, United Kingdom
1:00 PM
Masami Ono, MD, PHD1, Nobuhiro Miki, MD, PHD1, Tomokatsu Hori, MD, PHD2, Kosaku Amano, MD, PHD3 and Takakazu Kawamata, MD, PHD3, (1)Endocrinology and Metabolism, Tokyo Clinic, Tokyo, Japan
(2)Neurosurgery, Shin-Yurigaoka General Hospital, Kawasaki-city, Japan
(3)Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire